MedTrace Logo

Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes

NCT02692547 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-01-19

No results posted yet for this study

Summary

The purpose of this study is to collect data on the feasibility of the HLCL system in a camp setting.

Conditions

Interventions

DEVICE

Hybrid-logic closed loop system

All patients get to wear the pump

Sponsors & Collaborators

  • Medtronic Diabetes

    lead INDUSTRY

Principal Investigators

  • Moshe Philip, MD · National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-02-29
Completion
2016-02-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692547 on ClinicalTrials.gov